• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383559
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/22/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3.The date received by manufacturer has been used for this field.H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd nexiva sp with maxzero leaked at the septum.The following information was provided by the initial reporter: closed iv catheter system 18g piv inserted in patient arm.Apon successful flash blood began to leak out of the end of the catheter where the needle is removed from.Due to this iv was removed and an additional piv was inserted using a different iv lot number.
 
Additional Manufacturer Narrative
In response to the event reported by your facility a device history review was conducted for lot number 4242230.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections., additionally, a photo of the affected device was received for evaluation.The image displayed the unit leaking from the bottom of the adapter.The reported nonconformance has been confirmed.This type of defect may occur during the manufacturing process.Specifically, during the assembly of the secondary septum in the canister, it is possible for the septum to be improperly seated or damaged due to machine misalignment.Such conditions may result in leakage during use.Equipment design features are in place to ensure proper orientation and alignment of components to mitigate the occurrence of this issue.To prevent future occurrences of this event, our engineers have notified the appropriate manufacturing personnel of this event.
 
Event or Problem Description
No additional infromation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA SP WITH MAXZERO
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key22197622
Report Number1710034-2025-00998
Device Sequence Number13196531
Product Code FOZ
UDI-Device Identifier00382903835591
UDI-Public(01)00382903835591(11)240830(17)270831(10)4242230
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383559
Device Lot Number4242230
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/22/2025
Supplement Date Received by Manufacturer07/23/2025
Initial Report FDA Received Date06/12/2025
Supplement Report FDA Received Date07/28/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/30/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-